Evidence map›Paper›PMID 11238920›Full record

ArticleMolecular and cellular biology2001

c-myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice.

L Créancier, P Mercier, A C Prats, D Morello

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 91 citations in OpenAlex.

  1. IRES-Mediated Translation: Expanding the Toolkits of RNA Therapy.International journal of molecular sciences · 2025
    Review
  2. Long non-coding RNAeLife · 2022
    Article
  3. Article
  4. G-Quadruplex Regulation ofInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. The role of CSDE1 in translational reprogramming and human diseases.Cell communication and signaling : CCS · 2020
    Review
  8. IRES Trans-Acting Factors, Key Actors of the Stress Response.International journal of molecular sciences · 2019
    Review
  9. Review
  10. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. Article
  12. Internal ribosome entry site-based vectors for combined gene therapy.World journal of experimental medicine · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Preference of IRES-mediated initiation of translation during hibernation in golden-mantled ground squirrels, Spermophilus lateralis.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

L CréancierInstitut National de la Santé et de la Recherche Médicale U397, Endocrinologie et Communication Cellulaire, Institut Fédératif de Recherche Louis Bugnard, C.H.U. Rangueil, 31403 Toulouse Cedex 04, France.
P Mercier
A C Prats
D Morello
Inserm · FRCentre National pour la Recherche Scientifique et Technique (CNRST) · MAUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of c-myc proto-oncogene, a key regulator of cell proliferation and apoptosis, is controlled at different transcriptional and posttranscriptional levels. In particular, the c-myc mRNA contains an internal ribosome entry site (IRES) able to promote translation initiation independently from the classical cap-dependent mechanism. We analyzed the variations of c-myc IRES activity ex vivo in different proliferating cell types, and in vivo in transgenic mice expressing a bicistronic dual luciferase construct. c-myc IRES efficiency was compared to that of encephalomyocarditis virus (EMCV) IRES under the same conditions. The c-myc IRES was active but with variable efficiency in all transiently transfected cell types; it was also active in the 11-day- old (E11) embryo and in some tissues of the E16 embryo. Strikingly, its activity was undetected or very low in all adult organs tested. In contrast, EMCV IRES was very active in most cell types ex vivo, as well as in embryonic and adult tissues. These data suggest a crucial role of IRES in the control of c-myc gene expression throughout development, either during embryogenesis where its activity might participate in cell proliferation or later on, where its silencing could contribute to the downregulation of c-myc expression, whose deregulation leads to tumor formation.

Indexed as

Gene Expression Regulation, Developmental3T3 CellsAnimalsApoptosisBlotting, SouthernCell DifferentiationCell DivisionCells, CulturedChloramphenicol O-AcetyltransferaseCodonCodon, InitiatorCOS CellsFibroblast Growth Factor 2HeLa CellsHumansJurkat CellsChloramphenicol O-AcetyltransferaseCodonCodon, InitiatorFibroblast Growth Factor 2LuciferasesMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-myc

Identifiers

PMID11238920
PMCPMC86749
OpenAlexW2114261071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.